These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25080333)

  • 1. Surveillance snapshot: cases of service member meningococcal disease reported to the Naval Health Research Center Laboratory-based Meningococcal Disease Surveillance Program, 2006-2014.
    Broderick MP
    MSMR; 2014 Jul; 21(7):18. PubMed ID: 25080333
    [No Abstract]   [Full Text] [Related]  

  • 2. Surveillance of invasive meningococcal disease in the Czech Republic.
    Kriz P
    Euro Surveill; 2004 Nov; 9(11):37-9. PubMed ID: 15591689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.
    Popovic T; Sacchi CT; Reeves MW; Whitney AM; Mayer LW; Noble CA; Ajello GW; Mostashari F; Bendana N; Lingappa J; Hajjeh R; Rosenstein NE
    Emerg Infect Dis; 2000; 6(4):428-9. PubMed ID: 10905984
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.
    Brundage JF; Ryan MA; Feighner BH; Erdtmann FJ
    Clin Infect Dis; 2002 Dec; 35(11):1376-81. PubMed ID: 12439801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of Neisseria meningitidis in the vaccine era. Who needs what and when?
    Olcén P; Fredlund H
    Scand J Infect Dis; 2010; 42(1):4-11. PubMed ID: 19883161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal disease: the organism, clinical presentation, and worldwide epidemiology.
    Al-Tawfiq JA; Clark TA; Memish ZA
    J Travel Med; 2010; 17 Suppl():3-8. PubMed ID: 20849427
    [No Abstract]   [Full Text] [Related]  

  • 7. Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(46):1010-3. PubMed ID: 8965799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal disease.
    Rosenstein NE; Perkins BA; Stephens DS; Popovic T; Hughes JM
    N Engl J Med; 2001 May; 344(18):1378-88. PubMed ID: 11333996
    [No Abstract]   [Full Text] [Related]  

  • 9. Naval Health Research Center Surveillance for Meningococcal Disease.
    Broderick M; Myers C
    Mil Med; 2019 Mar; 184(Suppl 1):102-105. PubMed ID: 30901422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines.
    Ladhani SN; Flood JS; Ramsay ME; Campbell H; Gray SJ; Kaczmarski EB; Mallard RH; Guiver M; Newbold LS; Borrow R
    Vaccine; 2012 May; 30(24):3710-6. PubMed ID: 22429756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of meningococcal disease surveillance systems - United States, 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 May; 61(17):306-8. PubMed ID: 22552207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

  • 13. Group-C meningococcal conjunctivitis in a neonate.
    Dinakaran S; Desai SP
    Ocul Immunol Inflamm; 2000 Jun; 8(2):123-5. PubMed ID: 10980686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the Centers for Disease Control and Prevention. Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996.
    JAMA; 1996 Dec; 276(23):1866-7. PubMed ID: 8968001
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control.
    Can Fam Physician; 1994 Dec; 40():2121-3. PubMed ID: 7888825
    [No Abstract]   [Full Text] [Related]  

  • 16. [Meningococcus infection: problem actuality].
    Tereshchuk TO; Chugriiev AM
    Lik Sprava; 2011; (3-4):41-4. PubMed ID: 22416362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confronting the Epidemiology, Burden, Treatment, and Prevention of Meningococcal Disease.
    Middleman AB; Zimet GD
    J Adolesc Health; 2016 Aug; 59(2 Suppl):S1-2. PubMed ID: 27449144
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.
    Can Commun Dis Rep; 2006 Apr; 32(8):97-107. PubMed ID: 16685767
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigating the aetiology of and evaluating the impact of the Men C vaccination programme on probable meningococcal disease in England and Wales.
    Granerod J; Davison KL; Ramsay ME; Crowcroft NS
    Epidemiol Infect; 2006 Oct; 134(5):1037-46. PubMed ID: 16492318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.